These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34443331)

  • 1. ROCK2-Specific Inhibitor KD025 Suppresses Adipocyte Differentiation by Inhibiting Casein Kinase 2.
    Tran NNQ; Chun KH
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-adipogenic effects of KD025 (SLx-2119), a ROCK2-specific inhibitor, in 3T3-L1 cells.
    Diep DTV; Hong K; Khun T; Zheng M; Ul-Haq A; Jun HS; Kim YB; Chun KH
    Sci Rep; 2018 Feb; 8(1):2477. PubMed ID: 29410516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling the rationale and conducting a comprehensive assessment of KD025 (Belumosudil) as a candidate drug for inhibiting adipogenic differentiation-a systematic review.
    Barbalho SM; de Alvares Goulart R; Minniti G; Bechara MD; de Castro MVM; Dias JA; Laurindo LF
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):2681-2699. PubMed ID: 37966572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KD025 (SLx-2119) suppresses adipogenesis at intermediate stage in human adipose-derived stem cells.
    Diep DTV; Duong KHM; Choi H; Jun HS; Chun KH
    Adipocyte; 2019 Dec; 8(1):114-124. PubMed ID: 30860936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-adipogenic and Pro-lipolytic Effects on 3T3-L1 Preadipocytes by CX-4945, an Inhibitor of Casein Kinase 2.
    Yadav AK; Jang BC
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase CK2 is necessary for the adipogenic differentiation of human mesenchymal stem cells.
    Schwind L; Wilhelm N; Kartarius S; Montenarh M; Gorjup E; Götz C
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2207-16. PubMed ID: 26025678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KD025 Shifts Pulmonary Endothelial Cell Bioenergetics and Decreases Baseline Lung Permeability.
    Lee JY; Stevens RP; Kash M; Zhou C; Koloteva A; Renema P; Paudel SS; Stevens T
    Am J Respir Cell Mol Biol; 2020 Oct; 63(4):519-530. PubMed ID: 32628869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinalizarin inhibits adipogenesis through down-regulation of transcription factors and microRNA modulation.
    Schwind L; Nalbach L; Zimmer AD; Kostelnik KB; Menegatti J; Grässer F; Götz C; Montenarh M
    Biochim Biophys Acta Gen Subj; 2017 Dec; 1861(12):3272-3281. PubMed ID: 28964816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Rho Kinase Inhibitors on In Vitro Human Orbital Preadipocytes.
    Yoo D; Horacek M; Chae MK; Kim JY; Bu P; Yoon JS
    Ophthalmic Plast Reconstr Surg; 2024 Mar-Apr 01; 40(2):181-186. PubMed ID: 37995134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2.
    Cozza G; Mazzorana M; Papinutto E; Bain J; Elliott M; di Maira G; Gianoncelli A; Pagano MA; Sarno S; Ruzzene M; Battistutta R; Meggio F; Moro S; Zagotto G; Pinna LA
    Biochem J; 2009 Jul; 421(3):387-95. PubMed ID: 19432557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapy.
    Ruggeri E; Frezzato F; Mouawad N; Pizzi M; Scarmozzino F; Capasso G; Trimarco V; Quotti Tubi L; Cellini A; Cavarretta CA; Ruocco V; Serafin A; Angotzi F; Danesin N; Manni S; Facco M; Piazza F; Trentin L; Visentin A
    Front Immunol; 2024; 15():1393485. PubMed ID: 38807597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin suppresses leptin expression in 3T3-L1 adipocytes via activation of the cyclic AMP-PKA pathway induced by inhibition of protein prenylation.
    Maeda T; Horiuchi N
    J Biochem; 2009 Jun; 145(6):771-81. PubMed ID: 19254925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shikonin suppresses ERK 1/2 phosphorylation during the early stages of adipocyte differentiation in 3T3-L1 cells.
    Gwon SY; Ahn JY; Jung CH; Moon BK; Ha TY
    BMC Complement Altern Med; 2013 Aug; 13():207. PubMed ID: 23919458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase CK2 is implicated in early steps of the differentiation of pre-adipocytes into adipocytes.
    Wilhelm N; Kostelnik K; Götz C; Montenarh M
    Mol Cell Biochem; 2012 Jun; 365(1-2):37-45. PubMed ID: 22270543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pigment epithelium-derived factor suppresses adipogenesis via inhibition of the MAPK/ERK pathway in 3T3-L1 preadipocytes.
    Wang M; Wang JJ; Li J; Park K; Qian X; Ma JX; Zhang SX
    Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1378-87. PubMed ID: 19808909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KD025 Is a Casein Kinase 2 Inhibitor That Protects Against Glucolipotoxicity in β-Cells.
    Devkota R; Small JC; Carbone K; Glass MA; Vetere A; Wagner BK
    Diabetes; 2024 Apr; 73(4):585-591. PubMed ID: 38211571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the efficacy and selectivity of Ck2 inhibitors. A phosphoproteomics approach.
    Borgo C; Cesaro L; Hirota T; Kuwata K; D'Amore C; Ruppert T; Blatnik R; Salvi M; Pinna LA
    Eur J Med Chem; 2021 Mar; 214():113217. PubMed ID: 33548633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the Selective EP2 Receptor Agonist Omidenepag on Adipocyte Differentiation in 3T3-L1 Cells.
    Yamamoto Y; Taniguchi T; Inazumi T; Iwamura R; Yoneda K; Odani-Kawabata N; Matsugi T; Sugimoto Y; Shams NK
    J Ocul Pharmacol Ther; 2020 Apr; 36(3):162-169. PubMed ID: 31934812
    [No Abstract]   [Full Text] [Related]  

  • 19. APPL1 knockdown blocks adipogenic differentiation and promotes adipocyte lipolysis.
    Wen Z; Tang Z; Li M; Zhang Y; Li J; Cao Y; Zhang D; Fu Y; Wang C
    Mol Cell Endocrinol; 2020 Apr; 506():110755. PubMed ID: 32045627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Rho kinase 2 (ROCK2)-specific inhibitor KD025 ameliorates the development of pulmonary arterial hypertension.
    Yamamura A; Nayeem MJ; Sato M
    Biochem Biophys Res Commun; 2021 Jan; 534():795-801. PubMed ID: 33160621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.